Approval for Xeltis’s aXess device was based on pivotal trial data that demonstrated 79% secondary patency and a patency ...

Minneapolis-based FLEX Vascular announced the presentation of 12-month results from the FLEX FIRST AV Registry, a prospective ...

Please provide your email address to receive an email when new articles are posted on . Of the nearly 783,000 Americans with kidney failure, approximately 500,000 of these patients require ...

Rising demand for long-term intravenous therapies, expanding outpatient care, and innovation in safety-engineered devices are ...

One-third of older patients with end-stage kidney disease received an arteriovenous fistula within 6 months of starting ...

Hispanic patients initiating hemodialysis in the US were less likely to receive predialysis nephrology care and had lower rates of usable vascular access at dialysis initiation than White patients.

Proven percutaneous AV fistula technology set to re-enter the market with phased rollout in 2026 ...

In 2016, the American College of Emergency Physicians (ACEP) issued a policy statement advocating a new safety goal for vascular access: the “one-stick standard.” To help clinicians achieve it, ACEP ...

Dynamic Infusion Therapy, which is backed by RiverGlade Capital, has acquired Austin-based Vascular Access Consultants, a provider of expert services to healthcare facilities. No financial terms were ...

The future of healthcare is not just about treating patients when they come to the clinic. It is also about developing systems that help identify potential risks earlier and extend care beyond ...

For years transfemoral access was the predominant approach for cardiac procedures, but transradial cardiac interventions have recently gained substantial and rapid growth in the United States.